If your skin starts itching, feels irritating, or feels dry right after using a new skincare product, you’re probably dealing ...

UNLOXCYT (cosibelimab-ipdl) is indicated for the treatment of adults with metastatic cutaneous squamous cell carcinoma (“cSCC”) or locally advanced cSCC who are not candidates for curative surgery or ...